+987.9%
MRNA vs ALHC
-51.4%
+1,039.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ALHC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +10.1% | +3.0% | +12.2% |
| 7D | +20.6% | -0.5% | +21.1% | +20.4% |
| 30D | +27.1% | -4.2% | +31.4% | +26.9% |
| 3M | +353.4% | -39.8% | +393.2% | +374.2% |
| 6M | +446.3% | -57.7% | +504.0% | +532.5% |
| YTD | +776.2% | -58.8% | +834.9% | +901.0% |
| 1Y | +987.9% | -52.4% | +1,040.3% | +1,080.8% |
| All | +987.9% | -51.4% | +1,039.3% | +1,080.8% |
Cumulative growth
Daily Returns
Daily percentage return beside ALHC.
Daily Out/Under-Performance
Portfolio return minus ALHC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ALHC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ALHC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling